laetrile - Cancer Science

What is Laetrile?

Laetrile, also known as amygdalin or vitamin B17, is a compound that has been promoted as an alternative cancer treatment. It is derived from the seeds of certain fruits, such as apricots, and from some other plants. Proponents claim that laetrile can help treat cancer by targeting and killing cancer cells without harming normal cells. However, its efficacy and safety remain highly controversial.

Mechanism of Action

Laetrile is purported to work by releasing cyanide when it is metabolized in the body. The theory is that cancer cells contain higher levels of an enzyme called beta-glucosidase, which breaks down laetrile to release cyanide and benzaldehyde, substances thought to selectively kill cancer cells. Normal cells are believed to be protected by a different enzyme, rhodanese, which detoxifies cyanide. However, scientific evidence supporting this mechanism is lacking.

Clinical Evidence

Despite anecdotal reports of success, clinical trials have not demonstrated any significant benefit of laetrile in treating cancer. In fact, the National Cancer Institute (NCI) conducted clinical studies in the 1970s and found no evidence that laetrile is effective against cancer. The American Cancer Society and other major health organizations also do not support its use due to the lack of substantial evidence and potential risks.

Legal Status

The use of laetrile as a cancer treatment is not approved by the Food and Drug Administration (FDA) in the United States. It is illegal to sell laetrile as a cancer treatment in many countries, including the U.S. However, it is still available in some alternative medicine circles and can be obtained in certain countries where regulations are less stringent.

Risks and Side Effects

One of the primary concerns with laetrile is its potential to cause cyanide poisoning. Symptoms of cyanide toxicity include nausea, vomiting, headaches, dizziness, liver damage, and even death. There have been reported cases of severe toxicity and death associated with laetrile use. Therefore, its use poses significant health risks, especially if taken in large doses.

Alternative Cancer Treatments

Given the risks associated with laetrile, it is crucial to consider other evidence-based treatments for cancer. Conventional treatments like surgery, chemotherapy, and radiation therapy have been extensively studied and are proven to be effective in many cases. Additionally, new treatments such as immunotherapy and targeted therapy offer promising results. Patients should always consult with healthcare professionals to explore the best treatment options available.

The Role of Misinformation

The promotion of laetrile is often fueled by misinformation and conspiracy theories. Some proponents argue that the medical establishment suppresses alternative treatments to protect pharmaceutical companies' profits. However, these claims are not supported by scientific evidence. It is essential for patients to seek information from reputable sources and consult medical professionals before considering alternative treatments like laetrile.

Consulting Healthcare Professionals

If you or a loved one is considering laetrile as a cancer treatment, it is vital to discuss this with a healthcare professional. They can provide evidence-based advice and help you weigh the potential benefits and risks. It is also crucial to disclose all alternative treatments and supplements you are taking to avoid harmful interactions with conventional therapies.

Conclusion

Laetrile remains a controversial and largely unsupported treatment for cancer. While it continues to be promoted in some circles, the lack of scientific evidence and potential risks make it a questionable choice. Patients should prioritize evidence-based treatments and consult healthcare professionals to make informed decisions about their cancer care.



Relevant Publications

Issue Release: 2016

Issue Release: 2015

Issue Release: 2011

Partnered Content Networks

Relevant Topics